Locomotor sensitization to quinpirole: Environment-modulated increase in efficacy and context-dependent increase in potency

Psychopharmacology

Volumn 134, Issue 2, 1997, Pages 193-200

  Szumlinski, Karen K ^a   Allan, Melissa ^a   Talangbayan, Hazel ^a   Tracey, Alison ^a   Szechtman, Henry ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Context independent sensitization; Context dependent sensitization; D2 D3 agonist; Dose response; Efficacy; Locomotion; Potency; Rats

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SENSITIZATION; DRUG TOLERANCE; ENVIRONMENTAL FACTOR; LOCOMOTION; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CONDITIONING, OPERANT; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENT; MALE; MOTOR ACTIVITY; QUINPIROLE; RATS;

EID: 0030813682     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050442     Document Type: Article

References (59)

1. Ahmed SH, Stinus L, Le Moal M, Cador M (1993) Controlling interindividual differences in the unconditioned response to amphetamine in the study of environment-dependent sensitization. Behav Pharmacol 4: 355-365
2. Angrist B (1983) Psychosis induced by central nervous system stimulants and related drugs. In: Cresse I (ed) Stimulants: neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp 1-30
3. Antelman SM (1988) Stressor-induced sensitization to subsequent stress: Implications for the development and treatment of clinical disorders. In: Kalivas PW, Barnes CD (eds) Sensitization in the nervous system. Telford Press, New Jersey, pp 227-254
4. Antelman SM, Chiodo LA (1983) Amphetamine as a stressor. In: Creese I (ed) Stimulants: neurochemical, behavioral, and clinical perspectives. Raven Press, New York, pp 269-299
5. Baker TB, Tiffany ST (1985) Morphine tolerance as habituation. Psychol Rev 92: 78-108
6. Bardo MT, Bowling SL, Pierce RC (1990) Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli. Psychopharmacology 101: 338-343
7. Beninger RJ, Hahn BL (1983) Pimozide blocks the establishment but not expression of amphetamine-produced environment-specific conditioning. Science 220: 1304-1306
8. Castro R, Abreu P, Calzadilla, CH, Rodriguez M (1985) Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval. Psychopharmacology 85: 333-339
9. Chen J, Nye HE, Kelz MB, Hiroi N, Nakabeppu Y, Hope BT, Nestler EJ (1995) Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol Pharmacol 48: 880-889
10. Dragunow M, Logan B, Laverty R (1991) 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801. Eur J Pharmacol 206: 255-258
11. Eilam D, Szechtman H (1989) Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 161: 151-157
12. 2 agonist quinpirole. Pharmacol Biochem Behav 36: 989-991
13. 2 dopamine agonists on stereotyped locomotion in rats. Behav Brain Res 45: 117-124
14. 2 receptors. Psychopharmacology 106: 447-454
15. Einat H, Szechtman H (1993a) Long-lasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats. Behav Brain Res 54: 35-41
16. Einat H, Szechtman H (1993b) Environmental modulation of both locomotor response and locomotor sensitization to the dopamine agonist quinpirole. Behav Pharmacol 4: 393-403
17. Einat H, Einat D, Allan M, Talangbayan H, Tsafnat T, Szechtman H (1996) Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole. Psychopharmacology 127: 95-101
18. Ellinwood EH (1968) Amphetamine psychosis. II. Theoretical implications. J Neuropsychiatr 4: 45-54
19. Ellison GD (1979) Animal models of psychopathology: studies in naturalistic colony environments. In: Keehn JD (ed) Psychopathology in animals. Academic Press, New York, pp 81-101
20. 2 receptor agonists on rotational behavior and dopamine receptor binding. Eur J Pharmacol 236: 385-393
21. Franklin SR, Tang AH (1996) Quinpirole-induced locomotor stimulation in rats develops rapid sensitization when combined with brief footshocks. Behav Pharmacol 7: 94-100
22. Gold LH, Swerdlow NR, Koob GF (1988) The role of the mesolimbic dopamine in conditioned locomotion produced by amphetamine. Behav Neurosci 102: 544-552
23. Graybiel (1990) Amphetamine and cocaine induce drug-specific activation of c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 87: 6912-6916
24. Hinson RE, Siegel S (1983) Anticipatory hyperexcitability and tolerance to the narcotizing effect of morphine in the rat. Behav Neurosci 97: 759-767
25. Hirabyahi M, Okada S, Tadokoro S (1991) Comparison of sensitization to ambulation-increasing effects of cocaine and methamphetamine after repeated administration in mice. J Pharm Pharmacol 43: 827-830
26. 2 agonist bromocriptine show environment-specific sensitization following repeated injections. Psychopharmacology 107: 277-284
27. Kokkinidis L, Anisman H (1980) Amphetamine models of amphetamine paranoid schizophrenia: an overview and elaboration of animal experimentation. Psychol Bull 88: 551-579
28. 2 synergism and its breakdown. Brain Res 728: 97-104
29. Levant B, Moehlenkamp JD, Morgan KA, Leonard NL, Cheng CC (1996) Modulation of [H-3]quinpirole binding in brain by monoamine oxidase inhibitors: evidence for a potential novel binding site. J Pharmacol Exp Ther 278: 145-153
30. Levine RR (1990) Pharmacology: drug actions and reactions. 4th edn. Little Brown, Boston, Toronto, London
31. Mandel RJ, Hartgraves SL, Severson JA, Woodward JJ, Wilcox RE, Randall PK (1993) A quantitative estimate of the role of striatal D-2 receptor proliferation in dopaminergic behavioral supersensitivity: the contribution of mesolimbic dopamine to the magnitude of 6-OHDA lesion induced agonist sensitivity in the rat. Behav Brain Res 59: 53-64
32. 2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres. Brain Res 632: 308-313
33. Mattingly BA, Gotsick JE (1989) Conditioning and experimental factors affecting the developments of sensitization to apomorphine. Behav Neurosci 103: 1311-1317
34. Muller P, Seeman P (1979) Presynaptic subsensitivity after neuroleptics: time-course and specificity. Psychopharmacology 60: 1-11
35. Nestler EJ (1995) Molecular neurobiology of drug addiction. Neuropsychopharmacology 11: 77-87
36. Peris J, Boyson SJ, Cass WA, Curella P, Dwonskin LP, Larson G, Lin L-H, Yasuda RP, Zahniser NR (1990) Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J Pharmacol Exp Ther 253: 38-44
37. Piazza PV, Deminière JM, LeMoal M, Simaon H (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245: 1511-1513
38. Post RM, Contel NR (1981) Cocaine-induced behavioral sensitization: a model for recurrent manic illness. In: Perris C, Struwe G, Jansson B (eds) Biological psychiatry. Elsevier, Amsterdam, pp 746-749
39. Post RM, Weiss SRB (1988) Sensitization and kindling: Implications for the evolution of psychiatric symptomatology. In: Kalivas PW, Barnes CD (eds) Sensitization in the nervous system. Telford Press, New Jersey, pp 257-291
40. Post RM, Lockfeld A, Squillace KM, Contel NR (1981) Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization. Life Sci 28: 755-760
41. Randall P (1988) Quantitative analysis of behavioral pharmacological data. Ann N Y Acad Sci 515: 124-141
42. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11: 157-198
43. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of drug addiction. Brain Res Rev 18: 247-291
44. Segal DS, Schuckit MA (1983) Animal models of stimulant-induced psychosis. In: Creese I (ed) Stimulants: neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp 131-167
45. Stewart J, Badiani A (1993) Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4: 289-312
46. Stewart J, Vezina P (1989) Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res 495: 401-406
47. Stewart J, Vezina P (1991) Extinction procedures abolish conditioned stimulus control but spare sensitized responding to amphetamine. Behav Pharmacol 2: 65-71
48. Subramaniam S, Lucki I, McGonigle P (1992) Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Brain Res 571: 313-322
49. Szechtman H, Talangbayan H, Eilam D (1993) Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole. Behav Pharmacol 4: 405-410
50. Szechtman H, Dai H, Mustafa S, Einat H, Sullivan RM (1994a) Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole. Pharmacol Biochem Behav 48: 921-928
51. Szechtman H, Talangbayan H, Canaran G, Dai H, Eilam D (1994b) Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism. Psychopharmacology 115: 95-104
52. Terwilliger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, Nestler EJ (1991) A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548: 100-110
53. Tilson HA, Rech RH (1973) Conditioned drug effects and absence of tolerance to d-amphetamine induced motor activity. Pharmacol Biochem Behav 1: 149-153
54. Van Hartesveldt C, Cottrell GA, Potter T, Meyer ME (1992) Effects of intracerebral quinpirole on locomotion in rats. Eur J Pharmacol 214: 27-32
55. Willner P, Papp S, Cheeta S, Muscat R (1992) Environmental influences on behavioural sensitization to the dopamine agonist quinpirole. Behav Pharmacol 3: 43-50
56. Willner P, Sanger D, Emmett-Oglesby M (1993) Editorial. Behav Pharmacol 4: 287-288
57. Wise RA, Leeb K (1993) Psychomotor-stimulant sensitization: a unitary phenomenon? Behav Pharmacol 4: 339-349
58. Zeigler S, Lipton J, Toga A, Ellison G (1991) Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior. Brain Res 552: 27-35
59. Zhou LW, Qin ZH, Weiss B (1991) Down-regulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole. Neuropharmacology 4: 47-55